Juan Carlos Izpisua Belmonte, Altos Labs | All-In Summit 2024
757 segments
[Music]
scientists think they found the Fountain
of Youth what I think will become the
cover story on magazines that humans
have discovered the Fountain of Youth
and this will arise from yamanaka Factor
based cell reprogramming methods it
feels like a piece of technology that's
fallen through a wormhole from the
future it does sound a little bit like
science fiction A3 billion investment
that was just made in Altos Labs which
is probably one of the biggest seed
Investments ever he has made seminal
contributions to understanding stem cell
reprogramming so at this time it's my
pleasure to introduce our uh recipient
this year Juan Carlos espia
[Music]
[Applause]
[Music]
belante good afternoon my name is Juan
Carlos
Belmonte I'm going to start my
participation with a rather provocative
question which is
can we rejuvenate an
organism and if so what is the
implication of that respon for human
health for human
disease so the the book of Our Lives is
given to us when we are born our parent
past has this set of instruction these
millions and millions of letters that
constitute our
genome and by and large this is a very
solid process but every now and then
there is mistakes in these
letters and they may have importance for
our life or may be
irrelevant let me give you an example
for instance you change in this
case a c to a
t you're going to have a phenotype that
is depe here the these kids they are in
the picture between 6 and 10 years old
but they look much older they're really
all and they're not going to pass their
teenage H age and just because of this
small mutation a c into a
t now fortunately in the last few years
we scientists have developed method by
which we can reverse that change we can
fix that mistake and for instance we
have models in the lab we have animal
models in this case is a mouse where we
have created the same
mutation the C into a t and this mouse a
lab mouse lives for about 2 years this
mouse will live just for a couple of
month three four months maximum and it
will have the same accelerated aging
process of the human but we can fix this
we can change this T back into a c and
we get this mouse which has nothing to
do with the previous Mouse is healthier
live longer and is able to regenerate
some of their tissues that before it
couldn't do
it the problem as I was indicating
before is that
um this is a very small percentage of
the mistakes that happen in our life by
and large this is less than 1% there is
mistakes that generate diseases like
this by and large we have many other
diseases that are not due to a mutation
in our
genome and if we look at this graphic
that represent age and the possibility
of
death you can see that after certain
number of years around 4
45 the major risk factor for getting any
disease is precisely that years
age so the
longer we live The increased risk to get
diseased and around 40 45 we start to
develop all these diseases that you see
at the top of the
screen and they are not related to
changes into C or a t or a particular
mutation so how this
happen how these diseases appear and
what can we do about reversing these
diseases so let's go down to the cell
level here you have two type of cells a
very young cell healthy
cell and an all an unhealthy
cell the healthy cell is very res
resilien in the presence of risk factors
it has a very strong buffer capacity we
call that that can deal with
these these stresses however the all an
unhealthy cell in addition to the fact
that has been exposed because of time to
more factors excuse me it has less
buffer capacity it's less resilient to
these factors that damage reach the
cell and the question
that I want to present today has to deal
with this buffer capacity and what is
buffer capacity let's see if I can
explain this well so with time as time
passes there is more risk factors during
normal aging there is more stress and
the buffering capacity the resilient of
these cells goes go down and when these
two arrows these two curve mix the Seas
appear and the question is can we
increase buffer capacity so that then
the disease appears later or it never
appear can we increase the cell
resilience to deal with the disease that
appearing with aging when we are
young we really don't think about AG
when we are all a big percentage of our
days is just thinking how bad I feel and
what can I do so can we increase this
buffer capacity so that disease doesn't
appear it takes longer to appear or we
can even reverse it and how can this be
done just pause for a moment what is
aging what makes that cell fragile
unhealthy many things our metab po
change with
ag our energy levels drop our
mitochondria don't produce that ATP that
is needed for the cell to work
properly stem cells in our body die many
things happen while we
age but I'd like to Poe the idea that
among all these things that happen
during aging there is one very important
thing that could help to increase this
buffer capacity and this has to do with
what we call the epig
genome Epi comes from the Greek above
above our genome above the instructions
that we receive from our
parents and if we look at the cell and
the The genome the DNA of of any cell is
is very big it will take approximately 6
ft if we were to extend it
here but we need to pack it inside a
cell and it has a special
conformation bounded by the specific
proteins which in a very basic way we
can divide it in in a confirmation that
is open for business that we call open
chromatin or close for business close
chromatin and just this changing the
conformation of the chromatine may have
huge effect in the health
of the cell and the
organism in the time when the disease
appears and the first and most important
experiment to demonstrate this was done
by Dr s
yamanaka where what he did was a very
simple experiment he took four
genes added to an adult cell a cell that
is fragile that is
unhealthy and make that cell an
embrionic like cell
again and he did this by changing this
confirmation of the
chromatin now can this help us this
experiment for which he was awarded the
Noel price can this help us deal with
the problem I am trying to convey today
reverse disease bring back time and make
the cell more resilient and healthy
again so through a few years of studies
the message is this that there is a
correlation between the conformation of
the chromatin aging and disease when the
epigenome when the chromatine is closed
we call this
heterochromatin the cell is Young is
healthy when the chromatin is open it
leads
to the increase the loss of buffer
capacity and therefore disease and aging
and the question is can we reverse that
can we this correlation can we do
something to alter the confirmation of
this chromatin and demonstrate that just
by bringing an open chromatine to a
closed chromatine we can rejuvenate a
cell and how do we do that we took
advantage
of the initial ideas and studies of s
yamanaka and using again this mouse
model that I indicated before this
animal that has a
mutation that has a c into a te that
leads to an accelerated aging you can
see the animal here doesn't have hair
it's small it's not going to leave for
too long and what we did we took these
four factors So-Cal yamanaka factors and
put it inside this mouse this old mouse
we're not fixing the mutation remember
at the beginning there is Technologies
by which we can fix the mutation what
we're doing here is just altering the
chromatin the mutation is still there in
this mouse the cause of the problem that
letter is still there not fixed but
we're altering the
chromatin and we do this not
continuously we just do short pulses of
the yamanaka factors we put just during
the weekend we put these factors not
during the entire week to this mouse and
what happen is that we get a very
different Mouse healthy mouse that is
able to live
longer and remember we have not fixed
the mutation the te is still there so
just by this small change in the
chromatin we can rejuvenate a
mouse and here is the just example of
what I'm telling you we can either with
very precise tools that we have
developed correct bre a specific
mutation at the top the C to a t or
without knowing the mutation just that
we know that this Mouse has a problem we
just alter the status of the chromatine
and we practically get the same
phenotype we get Rejuvenation on this
mouse either genome correction or
epigenome buffering increasing the
capacity the buffering capacity of this
mouse so we have gone through from the
initial point to a later point where the
mouse will live longer and will have a
healthier
life now anyone could tell me yes you
are telling me just about one case this
particular mouse that has this mutation
does it work for something else for
other
diseases and the answer is yes let me
tell you just one more example and a few
others in a summary here we have another
mutation these mice have a mutation in a
gene called
leptine which make these mice eat all
the time and as such they get fat they
change their metabolism they get older
faster Etc if we just give a short pulse
of these yamanaka factors we get this
mouse the mouse still keeps eating
because it has the mutation we haven't
corrected but the mouse now has less fat
in the the liver and can respond to
glucose like a
normal young and healthy
Mouse and if we extend now and I don't
have time to go through this to many
other diseases that we have test in the
lab kidney disease skin disease liver
disease muscle disease Etc the same
thing happen we can bring back this
buffer capacity and make the cell
younger and the mouse younger
there's a sentence there that says a
deceased agnot this approach when you
are you have a problem you have a
disease you go to the doctor and it give
you a medicine but if you have another
disease it give you another medicine if
we have a mouse with a mutation we try
to correct that mutation another mouse
with another disease we correct that
mutation but what I'm telling with this
slide is that independent of the disease
just by this small switch of changing
the chromatin we can
increase the capacity of resilience of
this mouse so that the disease takes
longer or is even
reverse I think this is a very profound
message that is not very precise we are
not touching the genome we're touching
the epigenome but without this Deion we
can revert
disease now the key question is this is
great I told you can we rejuvenate an
organism at the beginning it seems that
based on this and other
experiments in Rodin in the lab the
answer is yes we take mice with
different pathologies we pass them
through these short pulses of yamanaka
factors and they they're better the the
disease takes longer to appear they live
longer
but even though in science this this
animal is the one that we know more
about health and disease much more than
humans our interest is healthy people
would this work in humans and this is
our mission in Aldos try to by this
cellular Rejuvenation
programming increase the buffer capacity
of a human cell so that the Sease is
reversed or can take longer to
appear we have done this in isolated
human cells in the
petrides but the next step is to move to
a human being an entire organism like
the
mouse and this has to be done so that
there is with all the safety and all the
precautions so that we do not harm when
this experiment is done these mice are
healthy healthy they're fine there is
nothing wrong with them but we need to
really be very cautious when touching a
human
cell so rather than delivering these
factors inside inv Vivo of a human being
what if we do it ex Vio and here is an
example organ transplant we know that
organ donations save thousands and
thousands of lives every year in our
planet but nonetheless there are many
thousands of organs that are discarded
because their quality because they are
all the doctor when the organ
comes look at the organ and said this is
this organ is not good enough doesn't
have enough quality to be transplanted
and it just get
discarded what if instead of going
directly into a human being we try to
rejuvenate this organ that is
discarded and see if the doctor now will
say now this organ is ready to be
transplanted whatever conditions and
quality requir by this doctor and we are
making progress into this area you can
see here when we
transplant ER in this case is still in
Rodin an all
kidney into a young rat and we compare
this with the transplantation of a young
kidney the life of the horse is very
different you see these two the green
and the blue lines so the
blue line is with no treatment the green
line is after a short pulse of these
factors that is given X Vivo to this
organ before it's transplanted and that
lead to an increase in the survival of
the hor so that's one way to start
approaching of moving this technology
that we are developing in the lap in
mice into humans but at the same time
there's one thing that and I'm finishing
there is one thing that I would like to
stress it's not that all the cells of
our organism go bad with time otherwise
we'll be dead there just a few cells and
with time there is more and more of
these fragile unhealthy cells that don't
have enough buffer capacity and you can
see this in this diagram the blue dots
indicate that with time we have more and
more of these nonfunctional cells but
what we don't want to touch is what is
working we don't want to deliver these
factors to cells that are healthy and
that are
functional how do we deliver these
factors just to those cells that are not
work work into these blue cells so you
see here the two H situation in a y
tissue you almost don't have any of
these fragile and healthy cells and how
can we deliver the factors just in the
age situation to the unhealthy cells but
we don't touch we don't want to touch
the healthy cells and this is what we we
have been doing there is a specific
genes and markers that Target and
identify by the unhealthy cell and with
these markers we can guide our yamanaka
factors just to the unhealthy cell and
we obtain the same phenotype you can see
here an increase in life span just
targeting the unhealthy cell increasing
the buffering capacity of the unhealthy
cell and the last slide that I want to
show you is for instance an organ like
the skin if we bring these factors to
the non healthy cell of the skin you see
phenotypes like this for instance an old
mouse like us with time will get gray
hair it would just bring the factors to
the unhealthy cells of the of the skin
that
produce this deterioration of function
now you see that the gray hair doesn't
appear or if we do a wound in the skin
of an animal of an animal and this in us
after a certain age the wound takes a
long time to close or even it doesn't
close you can see at the top the
nontreated in red there is there is a
wound there that has doesn't heal while
the treated one even in a very very old
mouth it just make a perfect Skin So
summary of what I have told you today is
this that
there is what we call Precision Medicine
by which we
can fix some of these mutations errors
that our parent transmit into the book
of our life but that's less than 1% of
the diseases the majority of diseases
correlate with
age passing of the time and they don't
have anything to do with particular
mutations and without touching the
genome with this Precision medicine just
just modifying the conformational
structure of the chromatin we can bring
a disease and aged cell into a cell that
is more resilient and more functional
and certainly this type of experiment
and the messages that it open up the
question of can we rejuvenate a human
being and can we reverse diseas in human
thank you for your
[Applause]
right ju caros thank you for the
presentation I want to I I don't I don't
know if you can
overstate the significance of the
discovery you have made and it's funny
to me how it's not popular uh knowledge
at this point because of the results
that you and other
scientists have collected and the impact
it will have to literally restore uh
cellular health and and deage an
organism and um the yamanaka factors or
four proteins just just for Layman's
conversation there are four proteins
that's what a factor is it's a A protein
that causes a change in the epigenome
and unwinds parts of the DNA and as a
result new genes get turned on other
genes get turned off and the cell kind
of revitalizes it becomes young
again um you discovered that you can
actually and and they did this all the
and made the cells go back all the way
to being stem cells but what you
discovered was the ability to partially
ReStore youthfulness in the cells
through partial reprogramming and that's
a dose Factor you put a smaller amount
of the yanaka factors on the cells what
how do you control it and then I want to
ask a question um about if you put too
much does it then because I know there's
been tests in mice where you end up with
cancer because then the cells start
multiplying too quickly so maybe you can
tell us a little bit about what it means
to do partial reprogramming with the
amak what does partial mean very
important question thank you for let's
see if I can clarify this what Dr s
yamanaka did is something that we no one
in in science in general could believe
that you can bring an adult
cell to a start life again become an
embryo cell embryol likee cell an
embryonic stem cell can be whatever we
have more than 250 cell types in our
body our skin cell is different than our
eye cell is different than our brain
cell because different genes are turned
on and off in each of those cells they
have the same DNA but they have a
different epigenome different genes are
turned on perfectly explained thank you
so and
what I think it's so for people to get
that yeah what SAA did was just to
delete delete all that information the
identity of a skin cell of a heart cell
and bring it back to the very beginning
to the to the very first time when we
are born to this type of cells
now is when he was putting these factors
it's his factors the yamanaka factor for
a long time four proteins for four prot
four proteins put them on the cell this
happens now we don't want this imagine
if we were to put this in the
heart the key cell in the heart is
called cardom myosite and what it does
is beat so if we remove the identity
can't of that cell is not anymore a
cardom myosite and go back to an
embryonic cell the heart is not going to
beat if we do that in the liver theoy is
not going to do its function so doing
this going back in in time to really the
earli
stages it will not do good to our bodies
and then and cancer arises and then if
you bring and lose the identity of a
particular cell then you are open for
that cell to become something else right
like a cancer cell or a skin cell is
transformed into aite many wrong things
could happen we want to maintain the
identity of this cell
and the small switch here that we did as
you are asking me is rather than having
the factors for a long time we just gave
a short
pulse what that is doing is altering the
chromatin but for a very short time it's
a small shock and then the chromatin get
close and maintain its
identity the cardiomyocyte is a cardom
myosite has not gone back
to a different cell typee but its
function is much better this is so the
idea is just a short P of these proteins
which by the way these are the proteins
that s yamanaka discovered but I'm
convinced that there will be many other
proteins so that's organism that's the
next thing I wanted to ask you so it
sounds like the search is on in various
startups at Alto slabs for other
proteins that can do this but perhaps
not protein but smaller molecules
peptides or small molecules where
theoretically you could take a
pill and it would do the same thing is
that a
reality so I think that one of the
biggest inventions that we humans have
made is the place we're here today the
university the Curiosity the knowledge
to advance in things that we don't
understand um
and discovering what other proteins what
other factors could do the same thing
belongs to that domain of the Curiosity
and trying to increase our knowledge but
many times we need to try to apply this
knowledge and you're asking me how are
you going to deliver whatever factors
you discover into a human
being you can do this in the lab with
many other ways but ideally you would
like to just put that into
appeal and so here is where the other
important thing come and that's
industry by mixing the Bas
of
Academia this curiosity this trying to
understand how we can close and open the
chromatin with many other
factors with the experience the drive
and the focus of
Industry can we answer the question that
you are asking can we put these factors
or any other factors that alter the
chromatine into appeal this is precisely
our Endeavor try to make this safe and
available to can I ask you a more maybe
a more basic
question um if this buffer
capacity is essentially the insulation
that we are born with that then decays
so
young cell good buffer capacity old cell
no buffer capacity in very simple terms
based on your side what is the
scientific community's understanding
about how to minimize the rate of change
and the Decay by things that people in
this room can control where we live the
things that we're exposed to our food
supply do any of those things to your
understanding have an impact that's
measurable
and achievable by us today while we wait
for altos and others to deliver more
chemical manipulation of this huge
impact incredible question and really
huge impact just think of exercise we
have compare what are the changes in the
Cell between
exercise and the short pulses of Y Mana
factors and you couldn't believe the
similarities in the changes in gene
expression that exercise
th and how overlap these changes happen
when we do the yamanaka the sh PES of
yamanaka factors so things like exercise
but exercising what kind of exercise how
much how
often why you want to know the answer
too what don't laugh actually you know
what don't answer the question you can
tell us afterwards because they don't
care don't it's
[Applause]
fine and exercise things that your
mother will tell you eat less
exercise H when I say stress I mean it
stress to the cell that is going to
alter the epigenome so until we really
understand how these changes in
chromatine happen all these things that
we do sometime with our life really
improve the buffer capacity and has that
been published or studied in a way
that's digestible for Layman meaning
like whether it's intermittent fasting
or whether it's the the quantity of food
or whether it's you know specific forms
of exercise over another has that been
well studied enough that we can at a
minimum we can even just link to all of
this so that you guys can get this
information but is it out there this is
I would say the last 10 years have been
an
incredible jump into into these studies
so far most of them have been done in
animal models in the lab and we are
starting to translate this to humans um
for instance I just finish it's not I
think I can say that tomorrow it will be
just one of these molecules that
diabetic people take metformine to lower
down their glucose they can reprogram
the cells so that all the cognitive
function or not just rodents and this is
the key thing but of monkeys which are
99% % their book of life is very 99 9%
similar to us right it can reprogram
these cells and the cognitive abilities
of monkeys and their lifespan is
increased so this is coming this is not
something that is just this small Mouse
in the lab where we know a lot about
their health and disease but I feel the
next decade probably many of these
discoveries with the caveat that it's a
mouse and a mouse is not a human might
be translated to human you put a slide
up there where you had a obviously a
whole bunch of Target markets some were
autoimmune diseases some were cancers
some were more just general aging
um how do you decide or how do you
figure
out where there is the uh most real
application today because I part of it
is there's a obviously
Market issue of making sure you continue
to have capital and prove scientific
value but part of it is there may be
some small winds today in rare diseases
or something that could allow you to
commercialize this faster so how do you
think about which problems should come
first good question I put up there the
ex Vio example with the organ
transplant this is probably one of the
most cautious and safest safest approach
where say uh acute liver disease there's
nothing about this you're are going to
die in 3 days right and if an organ is
not there you can do nothing so acute
and and deadly diseases that could
happen could be an
initial um target for these type of
approaches um but again I I want to say
that even though we are trying to move
as fast as we can into humans and we are
doing this experimen in human cells in
the Petri a mouse is not a human and
this will need time to be replicated in
a human being before we wrap can we just
talk about how altto Labs is set up it's
probably got more funding than any other
private company in recent history it's
really incredible how the the maybe you
can tell us how how you've organized
this this work this Mission um and again
is reflecting on the importance that we
know so little and about the fundamental
science of what is behind this big
question is a question that we human
beings have have tried to approach since
ever how can we deal with disease with
aging so there is so many things we
don't no basic sign is needed so as a
startup you raised billions of dollars
to do a lot of core research as well as
product development and at the same time
in parallel yeah with all the safety
approaches that we can think of and we
were talking about one possible
example perhaps without knowing every
detail of how it works provided is safe
and could have a positive effect trying
to move this forward so it's a
combination of what we like to call the
base of basic science and the base of
Industry yeah well look I mean I don't
think there's a human on earth that will
uh not benefit and does not appreciate
the the effort and and obviously
everyone hopes that you guys are
extremely successful in both the
scientific and Commercial uh Pursuits I
it seems to me like as you guys have
your breakthroughs which I think you're
uh you're going to have given the
backing and people that are involved
over time uh partial cell reprogramming
could be one of the most profoundly
impactful technologies that humans have
ever discovered or invented so we
appreciate the work that you do and and
thank you for being here with us thank
you for thank you
[Applause]
Ask follow-up questions or revisit key timestamps.
This presentation explores the revolutionary potential of cellular reprogramming to combat aging and age-related diseases. By utilizing 'Yamanaka factors'—proteins that can reset a cell's epigenome—researchers have demonstrated the ability to rejuvenate cells and restore them to a more youthful, resilient state without altering their original genetic code. This approach, specifically 'partial reprogramming,' aims to boost the body's 'buffer capacity' to handle stress and disease. While currently tested in animal models, the mission is to translate these findings into human applications, potentially through ex-vivo organ rejuvenation or targeted treatments for age-associated conditions, while prioritizing safety and efficacy.
Videos recently processed by our community